iMedX acquires Prevalent and Axcension to launch business intelligence
Date: 2019-07-08   Author: Saipriya Iyer  Category: #news

iMedX acquires Prevalent and Axcension to launch business intelligence

Combined technology & teams will provide ground-breaking business intelligence solutions for healthcare providers

iMedX, Inc., a US-based health information & clinical documentation provider recently acquired Prevalent, Inc. & Axcension, Inc., both of which are established providers of healthcare analytics & revenue cycle management consulting services, cite sources.

Reportedly, the recent acquisition completes another phase of global strategy of iMedX, to augment healthcare technology & enable insight into operations for healthcare facilities, to improve patient care while reducing costs.

As per sources close to the matter, proprietary analytics technology from iMedX, Prevalent & Axcension has been combined to create a ground-breaking business intelligence solution for healthcare providers, that enables transparency & understanding across multiple systems.

Christopher Foley, Chairman & CEO of iMedX was reported to state that in the coming years, an inclusive analytics platform will be a requirement for every provider’s revenue cycle management workflow, which is accelerating the need for acquisitions by the company. He said that having detailed insight into billing operations will become a necessity as the company maximizes the reimbursement for the clients in a constantly evolving regulatory environment.

Foley added that these acquisitions have brought together the best teams & technologies to form one unified team, devoted to helping clients achieve operational & financial goals. The organization’s capabilities are getting comprehensive & it can now reach a broader set of healthcare clients along with achieving the goal of reducing costs & improving patient care across the U.S.

Reportedly, new iMedX Analytics will allow healthcare providers to make better decisions via a streamlined system to quickly explore all data of the organization. By advanced rules & automated monitoring, billing issues or potential areas of improvement can be easily identified and resolved. Existing iMedX products & services such as medical coding, medical transcription, consulting projects & coding education will also utilize the advanced technology to ensure maximum efficiency & increased return on investment for customers.

Source credits: https://www.prnewswire.com/news-releases/imedx-inc-launches-industry-leading-analytics-and-business-intelligence-with-acquisition-of-prevalent-inc-and-axcension-inc-300880448.html



About Author


Saipriya Iyer

Saipriya Iyer

Saipriya Iyer currently works as a content developer for AlgosOnline. A computer engineer by profession, she ventured into the field of writing for the love of playing with words. Having had a previous experience of 3 years under her belt, she has dabbled with website...

Read More

More from Saipriya


Post Recommendents

Global Food Enzymes Market Grow Analysis | COVID-19 Impact, Top Players, Threats, Trends, Challenges and Opportunities till 2024
Author: Rahul Varpe

The Decresearch Inc. offers latest report titled "Global Food Enzymes Market" 2017 - 2024 is a historical overview and detailed study on the current and future market of the Food Enzymes industry. The Food Enzymes Market was registered a...


Global Milk Fat Fractions Market Grow Analysis | COVID-19 Impact, Top Players, Threats, Trends, Challenges and Opportunities till 2024
Author: Rahul Varpe

The Decresearch Inc. offers latest report titled "Global Milk Fat Fractions Market" 2017 - 2024 is a historical overview and detailed study on the current and future market of the Milk Fat Fractions industry. The Milk Fat Fractions Marke...


Global Fish Protein Hydrolysate Market Grow Analysis | COVID-19 Impact, Risk Factors, Challenges and Opportunities till 2026
Author: Rahul Varpe

The Decresearch Inc. offers latest report titled "Global Fish Protein Hydrolysate Market" 2020 - 2026 is a historical overview and detailed study on the current and future market of the Fish Protein Hydrolysate industry. The Fish Protein...